Answers are grounded in this paper and cite their sources.
These results further support the role of adrenomedullin as a survival factor for tumors. Development of physiologically efficient inhibitors of adrenomedullin may prove useful in the clinical management of cancer.
No takes yet. Share an insight, caveat, or question.
Alfredo Martı́nez (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: